After 68 weeks, participants receiving a 2.4 mg weekly semaglutide dose experienced a 49% reduction in C-reactive protein (CRP), while those on a 1 mg weekly dose saw a 42% reduction compared to placebo
(en) Glutathione, reduced (GSH)
Impairments range from subtle effects that can only be detected with special tests at levels between 0.001-0.029%, to problems with concentration, reflexes, motor control, and more, including a serious possibility of death at 0.50% or more.
This piece was inspired by our recent interview with Theresa Yee, a London-based trend forecaster and journalist specializing in beauty and wellness
It wasnt just that there was an initial loss of muscle with the GLP-1 receptor agonist it also reduced the regenerative capacity of the young mouse muscles, said Minas Nalbandian, PhD, a postdoctoral scholar in the Blau lab and first author of the new paper
10.1038/s41598-021-89620-7 3